Keystone Labs Inc. has dedicated and experienced professionals to deliver quality testing solutions for regulated industry requirements. By offering a diverse selection of cGMP compliant analytical and biological testing services, Keystone Labs is able to adapt to meet all testing needs. Keystone's emphasis is on delivering customized solutions to  testing requirements and providing outstanding customer service. Their client management program ensures that projects are executed effectively and efficiently by employing a single point of contact for each client.

Network Immunology Inc.

Network Immunology Inc. is a vaccine company. The company’s focus is to commercialize a preventive HIV vaccine invented in 2005 by Dr. Geoffrey W. Hoffmann, the President and CEO of the company. The Network Immunology vaccine is for HIV negative persons. The technology is based on a theory of AIDS pathogenesis developed by Dr. Hoffmann (G. W. Hoffmann (1994) Co-selection in immune network theory and in AIDS pathogenesis, Immunology and Cell Biology, 72, 338-346). A key postulate of the theory was validated in a paper published eight years later (D. C. Douek et al. (2002) HIV preferentially infects HIV-specific CD4+ T cells. Nature, 417, 95-98).